Stockreport

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Certara, Inc.  (CERT) 
PDF Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence  Updated 2026 guidance to be provided upon transaction close RADNOR, Pa. [Read more]